J. Joseph Kim
2019
In 2019, J. Joseph Kim earned a total compensation of $2.6M as President and Chief Executive Officer at Inovio Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $457,222 |
---|---|
Option Awards | $642,803 |
Salary | $837,735 |
Stock Awards | $638,274 |
Other | $12,500 |
Total | $2,588,534 |
Kim received $837.7K in salary, accounting for 32% of the total pay in 2019.
Kim also received $457.2K in non-equity incentive plan, $642.8K in option awards, $638.3K in stock awards and $12.5K in other compensation.
Rankings
In 2019, J. Joseph Kim's compensation ranked 4,715th out of 13,971 executives tracked by ExecPay. In other words, Kim earned more than 66.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,715 | 66th |
Manufacturing | 1,757 | 69th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 242 | 71st |
Surgical, Medical, And Dental Instruments And Supplies | 139 | 74th |
Surgical and Medical Instruments and Apparatus | 86 | 75th |
Kim's colleagues
We found three more compensation records of executives who worked with J. Joseph Kim at Inovio Pharmaceuticals in 2019.
News
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019